• 
  Rama Al Hamed, Abdul Hamid Bazarbachi, Ali Bazarbachi, Florent Malard, Jean-Luc Harousseau, et al.. Comprehensive Review of AL amyloidosis: some practical recommendations. Blood Cancer Journal, Nature Publishing Group, 2021, 11 (5), pp.97. ⟨10.1038/s41408-021-00486-4⟩. ⟨hal-03231102⟩
• 
  G. Houvenaeghel, A. de Nonneville, M. Cohen, N. Chopin, C. Coutant, et al.. Lack of prognostic impact of sentinel node micro-metastases in endocrine receptor-positive early breast cancer: results from a large multicenter cohort☆. ESMO Open, 2021, 6 (3), pp.100151. ⟨10.1016/j.esmoop.2021.100151⟩. ⟨hal-03230902⟩
• 
  Christelle Duprez, Laurence Vanlemmens, Aurélie Untas, Pascal Antoine, Anne Lesur, et al.. Emotional distress and subjective impact of the disease in young women with breast cancer and their spouses. Future Oncology, Future Medicine, 2017, 13 (29), pp.2667-2680. ⟨10.2217/fon-2017-0264⟩. ⟨hal-02457803v2⟩
• 
  Thomas Aparicio, Nathalie Cozic, Christelle de la Fouchardière, Emeline Meriaux, Jérome Plaza, et al.. The Activity of Crizotinib in Chemo-Refractory MET-Amplified Esophageal and Gastric Adenocarcinomas: Results from the AcSé-Crizotinib Program. Targeted Oncology, Springer Verlag (Germany), 2021, ⟨10.1007/s11523-021-00811-8⟩. ⟨hal-03198137⟩
• 
  Marion Dhooge, Stéphanie Baert-Desurmont, Carole Corsini, Olivier Caron, Nadine Andrieu, et al.. National recommendations of the French Genetics and Cancer Group - Unicancer on the modalities of multi-genes panel analyses in hereditary predispositions to tumors of the digestive tract. European Journal of Medical Genetics, Elsevier, 2020, 63 (12), pp.104080. ⟨10.1016/j.ejmg.2020.104080⟩. ⟨inserm-03182974⟩
• 
  Marisa Capitao, Justine Perrin, Sylvain Simon, Sébastien Gouard, Nicolas Chouin, et al.. Anti-Tumor Efficacy of PD-L1 Targeted Alpha-Particle Therapy in a Human Melanoma Xenograft Model. Cancers, MDPI, 2021, 13 (6), pp.1256. ⟨10.3390/cancers13061256⟩. ⟨inserm-03171640⟩
• 
  Valentin Calugaru, Pascal Pommier, Paul Giraud, Philippe Giraud, Eliot Nicolas, et al.. Interpretable Machine Learning Model for Locoregional Relapse Prediction in Oropharyngeal Cancers. Cancers, MDPI, 2020, 13 (1), pp.57. ⟨10.3390/cancers13010057⟩. ⟨hal-03146371⟩
• 
  Marion Berdal, Sébastien Gouard, Romain Eychenne, Séverine Marionneau-Lambot, Mikaël Croyal, et al.. Investigation on the reactivity of nucleophilic radiohalogens with arylboronic acids in water: access to an efficient single-step method for the radioiodination and astatination of antibodies. Chemical Science , The Royal Society of Chemistry, 2020, Online ahead of print. ⟨10.1039/D0SC05191H.⟩. ⟨inserm-03024891⟩
• 
  Fabien Vidal, Paul Guerby, Mathieu Luyckx, Pascale Haddad, Eberhard Stoeckle, et al.. Are Early Relapses in Advanced-Stage Ovarian Cancer Doomed to a Poor Prognosis?. PLoS ONE, Public Library of Science, 2016, 11 (1), pp.e0147787. ⟨10.1371/journal.pone.0147787⟩. ⟨inserm-02940269⟩
• 
  Clément Palpacuer, Karima Hammas, Renan Duprez, Bruno Laviolle, John P A Ioannidis, et al.. Vibration of effects from diverse inclusion/exclusion criteria and analytical choices 9216 different ways to perform an indirect comparison meta-analysis. BMC Medicine, BioMed Central, 2019, 17 (1), pp.174. ⟨10.1186/s12916-019-1409-3⟩. ⟨hal-02304653⟩
• 
  R Da-Ano, Ingrid Masson, Felix Lucia, M. Dore, Patrice Robin, et al.. Performance comparison of modified ComBat for harmonization of radiomic features for multicenter studies. Scientific Reports, Nature Publishing Group, 2020, 10 (1), pp.10248. ⟨10.1038/s41598-020-66110-w⟩. ⟨hal-02887419⟩
• 
  Emmanuelle Bompas, Loïc Campion, Antoine Italiano, Axel Le Cesne, Christine Chevreau, et al.. Outcome of 449 adult patients with rhabdomyosarcoma: an observational ambispective nationwide study. Cancer Medicine, Wiley, 2018, Cancer medicine, 7 (8), pp.4023-4035. ⟨10.1002/cam4.1374⟩. ⟨hal-01978221⟩
• 
  Loic Lebellec, François Bertucci, Emmanuelle Tresch-Bruneel, Emmanuelle Bompas, Yves Toiron, et al.. Circulating vascular endothelial growth factor (VEGF) as predictive factor of progression-free survival in patients with advanced chordoma receiving sorafenib: an analysis from a phase II trial of the french sarcoma group (GSF/GETO). Oncotarget, Impact journals, 2016, Oncotarget, 7 (45), pp.73984-73994. ⟨10.18632/oncotarget.12172⟩. ⟨hal-01453300⟩
• 
  Pauline Rochefort, Antoine Italiano, Valérie Laurence, Nicolas Penel, Audrey Lardy-Cleaud, et al.. A retrospective multicentric study of ewing sarcoma family of tumors in patients older than 50: management and outcome. Scientific Reports, Nature Publishing Group, 2017, Scientific reports, 7, ⟨10.1038/s41598-017-17733-z⟩. ⟨hal-02613645⟩
• 
  Elodie Girard, Séverine Eon‐marchais, Robert Olaso, Anne‐laure Renault, Francesca Damiola, et al.. Familial breast cancer and DNA repair genes: Insights into known and novel susceptibility genes from the GENESIS study, and implications for multigene panel testing. International Journal of Cancer, Wiley, 2019, 144 (8), pp.1962-1974. ⟨10.1002/ijc.31921⟩. ⟨inserm-02438452⟩
• 
  Marion Couderc, Anne Tournadre, Sylvain Mathieu, Bruno Pereira, Martin Soubrier, et al.. Do the salivary glands of patients with systemic sclerosis show ultrasonographic modifications suggestive of Sjögren's syndrome?. Annals of the Rheumatic Diseases, BMJ Publishing Group, 2019, pp.annrheumdis-2019-215777. ⟨10.1136/annrheumdis-2019-215777⟩. ⟨hal-02343567⟩
• 
  Christophe Le Tourneau, Maud Kamal, Olivier Trédan, Jean-Pierre Delord, Mario Campone, et al.. Designs and challenges for personalized medicine studies in oncology: focus on the SHIVA trial. Targeted Oncology, Springer Verlag (Germany), 2012, 7 (4), pp.253-265. ⟨10.1007/s11523-012-0237-6⟩. ⟨inserm-02294308⟩
• 
  Flora Goupy, Stephane Supiot, David Pasquier, Igor Latorzeff, Ulrike Schick, et al.. Intensity-modulated radiotherapy for prostate cancer with seminal vesicle involvement (T3b) A multicentric retrospective analysis. PLoS ONE, Public Library of Science, 2019, 14 (1), pp.e0210514. ⟨10.1371/journal.pone.0210514⟩. ⟨hal-02049134⟩
• 
  L. Berger, Guillaume Boissonnat, H. Chesneau, V. Passal, J. Desrousseaux, et al.. IGRT kV-imaging dose MC calculations validated in anthropomorphic phantoms using OSL. ESTRO 37 - European SocieTy for Radiotherapy & Oncology, Apr 2018, Barcelona, Spain. Radiotherapy and Oncology, 127 (Supplement 1), S1004-S1005; poster EP-1860, 2018, ESTRO 37, April 20-24, 2018, Barcelona, Spain. ⟨10.1016/S0167-8140(18)32169-8⟩. ⟨hal-01878965⟩
• 
  Raphael Leman, Pascaline Gaildrat, Gerald L. Gac, Chandran Ka, Yann Fichou, et al.. Novel diagnostic tool for prediction of variant spliceogenicity derived from a set of 395 combined in silico/in vitro studies: an international collaborative effort. Nucleic Acids Research, Oxford University Press, 2018, 46 (15), pp.7913-7923. ⟨10.1093/nar/gky372⟩. ⟨hal-01910334⟩

45

104